Grant: Planning and Dissemination Grant - Institute Community Support
University of British Columbia
$20,000.00
Autoimmune Biomedical Collaborative (ABC) Annual Workshop
EF 2025-26
Résumé
A healthy immune system protects us from infections, but when not functioning properly can also attack the body's own healthy cells, causing an autoimmune disease. Autoimmune diseases such as rheumatoid arthritis, multiple sclerosis, and type 1 diabetes affect millions of Canadians. There are no cures for these diseases; current treatments are focused on managing symptoms and preventing further damage. Furthermore, treatment is complicated by differences in symptoms and treatment outcomes between different people, for reasons that are not clear. Thus, new ideas and approaches are needed.
The Autoimmune Biomedical Collaborative is a research initiative that aims to forge stronger connections and increase communication between scientists, doctors, and patient groups, to combine our diverse knowledge, perspectives, and experiences to better understand these diseases and develop more effective treatments. We propose to host an annual workshop, inviting a broad range of participants from across Canada and including global collaborators, to break down traditional boundaries and address two disparities that stand in the way of innovation for autoimmune diseases: first, bridging biomedical researchers, clinical scientists, and patient groups within a given autoimmune disease field, and second and more importantly, by bringing researchers focused on different autoimmune disease fields together to share their knowledge to uncover common mechanisms of disease and develop and test global therapeutic reagents. We are requesting funds from CIHR to invite an internationally-renowned Keynote speaker to the meeting, and travel funds to encourage trainee participation. This meeting will be unique in Canada - designed to pool broad expertise and foster relationship-building, generate innovative ideas, and improve processes to share access to valuable patient biobanks and unique pre-clinical animal models for testing disease mechanisms and therapeutics.
Programme
Planning and Dissemination Grant - Institute Community Support
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
531383
Name
Horwitz Marc S
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Planning and Dissemination Grants
Projecttitle
Autoimmune Biomedical Collaborative (ABC) Annual Workshop
Programtype2
Miscellaneous Programs
Orgnameinp2
University of British Columbia
Cihramount2
$20,000
Cihrequipment2
$0
Programname2
Planning and Dissemination Grant - Institute Community Support
Keyworddelim
Autoimmune Diseases; Basic-Clinical Research Partnerships; Common Mechanisms; Interdisciplinary Approaches; Knowledge Dissemination; Patient Advocacy; Resource Sharing; Therapeutics
Abstract
A healthy immune system protects us from infections, but when not functioning properly can also attack the body's own healthy cells, causing an autoimmune disease. Autoimmune diseases such as rheumatoid arthritis, multiple sclerosis, and type 1 diabetes affect millions of Canadians. There are no cures for these diseases; current treatments are focused on managing symptoms and preventing further damage. Furthermore, treatment is complicated by differences in symptoms and treatment outcomes between different people, for reasons that are not clear. Thus, new ideas and approaches are needed.
The Autoimmune Biomedical Collaborative is a research initiative that aims to forge stronger connections and increase communication between scientists, doctors, and patient groups, to combine our diverse knowledge, perspectives, and experiences to better understand these diseases and develop more effective treatments. We propose to host an annual workshop, inviting a broad range of participants from across Canada and including global collaborators, to break down traditional boundaries and address two disparities that stand in the way of innovation for autoimmune diseases: first, bridging biomedical researchers, clinical scientists, and patient groups within a given autoimmune disease field, and second and more importantly, by bringing researchers focused on different autoimmune disease fields together to share their knowledge to uncover common mechanisms of disease and develop and test global therapeutic reagents. We are requesting funds from CIHR to invite an internationally-renowned Keynote speaker to the meeting, and travel funds to encourage trainee participation. This meeting will be unique in Canada - designed to pool broad expertise and foster relationship-building, generate innovative ideas, and improve processes to share access to valuable patient biobanks and unique pre-clinical animal models for testing disease mechanisms and therapeutics.
Competitiondate
202506
Approvedterm2
1 yr 0 mth
Pinamesdelim
Horwitz, Marc S
Approvedterm
1 an 0 mois
Cihrcontribution2
III~ $20,000~ $0~